RESUMO
BACKGROUND: The hantavirus infection is an emerging zoonotic disease, endemic in Chile, generating the hantavirus cardiopulmonary syndrome (HCPS), characterized by cardiopulmonary dysfunction with rapidly progressive respiratory failure and high lethality. For an early clinical orientation of HCPS, due to its non-specificity in symptoms and to help the differential diagnosis, some laboratory parameter that may be useful have been studied. AIM: To identify laboratory criteria as predictive factors of HCPS in patients with suspected hantavirus infection. METHODOLOGY: Retrospective cohort study of 71 patients admitted to the Hospital Guillermo Grant Benavente Emergency. We determined discriminative capacity of laboratory's parameters at the time of admission: platelets recount, hematocrit, inmunoblasts, activated partial thromboplastin time (aPTT) and aspartate aminotransferase (AST/GOT). RESULTS: Were found significant differences in all parameters studied between confirmed patients (22) with respect to unconfirmed (49). Hematocrit, inmunoblasts, AST/GOT and aPTT had a OR > 1 and platelets count had a OR < 1. The best combination for predict HCPS was hematocrit, platelets count and AST/GOT with 90,01% sensibility and 81,63% specificity. CONCLUSION: The five parameters studied are good predictors of HCS in suspicious patients and they would may be useful in low complexity hospitals for quick transfer a center with critical care units.
Assuntos
Técnicas de Laboratório Clínico/normas , Síndrome Pulmonar por Hantavirus/diagnóstico , Aspartato Aminotransferases/normas , Chile , Feminino , Síndrome Pulmonar por Hantavirus/sangue , Hematócrito/normas , Humanos , Masculino , Tempo de Tromboplastina Parcial/normas , Contagem de Plaquetas/normas , Valor Preditivo dos Testes , Estudos Retrospectivos , População Rural , Sensibilidade e EspecificidadeRESUMO
BACKGROUND: Hantavirus cardiopulmonary syndrome (HCPS) has a mortality up to 35-40% and its treatment is mainly supportive. A variable to predict progression from mild to severe disease is unavailable. This study was performed in patients with documented infection by Andes orthohantavirus, and the aim was to find a simple variable to predict progression to moderate/severe HCPS in patients with mild disease at admission. METHODS: We performed a retrospective analysis of 175 patients between 2001 and 2018. Patients were categorized into mild, moderate, and severe disease according to organ failure and advanced support need at hospital admission (e.g., mechanical ventilation, vasopressors). Progression to moderate/severe disease was defined accordingly. Clinical and laboratory variables associated with progression were explored. RESULTS: Forty patients with mild disease were identified; 14 of them progressed to moderate/severe disease. Only platelet count was different between those who progressed versus those that did not (37 (34-58) vs. 83 (64-177) K/mm3, p < 0.001). A ROC curve analysis showed an AUC = 0.889 (0.78-1.0) p < 0.001, with a platelet count greater than 115K /mm3 ruling out progression to moderate/severe disease. CONCLUSIONS: In patients with mild disease at presentation, platelet count could help to define priority of evacuation to tertiary care centers.
Assuntos
Infecções por Hantavirus/sangue , Infecções por Hantavirus/complicações , Síndrome Pulmonar por Hantavirus/sangue , Trombocitopenia/complicações , Adulto , Chile , Progressão da Doença , Feminino , Infecções por Hantavirus/classificação , Humanos , Masculino , Pessoa de Meia-Idade , Contagem de Plaquetas , Curva ROC , Estudos Retrospectivos , Trombocitopenia/virologia , Adulto JovemRESUMO
Resumen Introducción: La infección por hantavirus es una zoonosis emergente, endémica en Chile, generando el síndrome cardiopulmonar por hantavirus (SCPH), caracterizado por disfunción cardiopulmonar con falla respiratoria rápidamente progresiva y altamente letal. Para una orientación clínica precoz del SCPH, debido a su poca especificidad en síntomas y ayudar al diagnóstico diferencial, se han estudiado algunos parámetros de laboratorio que puedan ser de utilidad. Objetivo: Identificar criterios del laboratorio como factores predictores del diagnóstico de SCPH en pacientes con sospecha de enfermedad por hantavirus. Metodología. Estudio de cohorte retrospectiva de 71 pacientes que ingresaron a Urgencia del Hospital Guillermo Grant Benavente. Se determinó la capacidad discriminativa de parámetros de laboratorio al momento de ingreso: recuento de plaquetas, hematocrito, inmunoblastos, TTPa y GOT. Resultados: Se encontraron diferencias significativas en los parámetros estudiados entre pacientes confirmados (n: 22) con respecto a los no confirmados (n: 49). Hematocrito, inmunoblastos, GOT y TTPa tuvieron un OR > 1 y las plaquetas un OR < 1. La mejor combinación para predecir SCPH fue hematocrito, plaquetas y GOT con sensibilidad 90,9% y especificidad 81,6%. Conclusión: Los cinco parámetros estudiados son buenos predictores de SCPH en pacientes con sospecha del mismo y podrían ser útiles en hospitales de baja complejidad para rápido traslado a centro que cuente con unidad de pacientes crítico.
Background. The hantavirus infection is an emerging zoonotic disease, endemic in Chile, generating the hantavirus cardiopulmonary syndrome (HCPS), characterized by cardiopulmonary dysfunction with rapidly progressive respiratory failure and high lethality. For an early clinical orientation of HCPS, due to its non-specificity in symptoms and to help the differential diagnosis, some laboratory parameter that may be useful have been studied. Aim: To identify laboratory criteria as predictive factors of HCPS in patients with suspected hantavirus infection. Methodology: Retrospective cohort study of 71 patients admitted to the Hospital Guillermo Grant Benavente Emergency. We determined discriminative capacity of laboratory's parameters at the time of admission: platelets recount, hematocrit, inmunoblasts, activated partial thromboplastin time (aPTT) and aspartate aminotransferase (AST/GOT). Results: Were found significant differences in all parameters studied between confirmed patients (22) with respect to unconfirmed (49). Hematocrit, inmunoblasts, AST/GOT and aPTT had a OR > 1 and platelets count had a OR < 1. The best combination for predict HCPS was hematocrit, platelets count and AST/GOT with 90,01% sensibility and 81,63% specificity. Conclusion: The five parameters studied are good predictors of HCS in suspicious patients and they would may be useful in low complexity hospitals for quick transfer a center with critical care units.
Assuntos
Humanos , Masculino , Feminino , Síndrome Pulmonar por Hantavirus/diagnóstico , Técnicas de Laboratório Clínico/normas , Tempo de Tromboplastina Parcial/normas , Contagem de Plaquetas/normas , Aspartato Aminotransferases/normas , População Rural , Chile , Valor Preditivo dos Testes , Estudos Retrospectivos , Sensibilidade e Especificidade , Síndrome Pulmonar por Hantavirus/sangue , Hematócrito/normasRESUMO
People living in mining regions are exposed to numerous biological agents by several specific types of transmission mechanisms. This study is designed to describe fatal hantavirus pulmonary syndrome (HPS) cases confirmed by serology and molecular analysis, where a seroprevalence survey was conducted in the gold mining regions of the state of Mato Grosso, in the official Amazon region, Brazil. Two fatal cases of HPS were confirmed in a mining area in the Legal Amazon, where malaria is one of the most important public health problems. A molecular analysis detected the presence of the genome of the Castelo dos Sonhos virus. Out of the 112 blood samples analyzed, five were positive for Plasmodium infection (four P. falciparum and one P. vivax), and four were seropositive for hantavirus, showing a seroprevalence of 3.57%. One of the four miners who was seroreactive for hantavirus concomitantly had P. falciparum infection, which was confirmed by thick blood smear. This manuscript highlights the importance of considering hantavirus pulmonary syndrome as a diagnostic possibility in febrile infection associated with pulmonary manifestations in mining areas where malaria cases are often identified.
Assuntos
Síndrome Pulmonar por Hantavirus/epidemiologia , Malária/epidemiologia , Adolescente , Adulto , Idoso , Brasil/epidemiologia , Criança , Pré-Escolar , Feminino , Ouro , Orthohantavírus/genética , Síndrome Pulmonar por Hantavirus/sangue , Síndrome Pulmonar por Hantavirus/microbiologia , Humanos , Lactente , Malária/sangue , Malária/microbiologia , Masculino , Pessoa de Meia-Idade , Mineração , Filogenia , Plasmodium/imunologia , Estudos Soroepidemiológicos , Adulto JovemRESUMO
BACKGROUND: Hantavirus pulmonary syndrome (HPS) is caused by Andes virus (ANDV) and related hantaviruses in the Americas. Despite a fatality rate of 40%, the pathogenesis of HPS is poorly understood and factors associated with severity, fatality, and survival remain elusive. METHODS: Ninety-three ANDV-infected HPS patients, of whom 34 had a fatal outcome, were retrospectively studied. Serum levels of cytokines and other inflammation-associated markers were analyzed using multiplex immunoassay and enzyme-linked immunosorbent assay. Associations with disease severity, fatal outcome, and survival were identified using logistic regression. RESULTS: HPS patients exhibited increased serum levels of markers associated with inflammation, intestinal damage, and microbial translocation compared to controls. Patients with fatal outcome displayed higher levels of interleukin (IL) 6, IL-10, interferon-γ, soluble tumor necrosis factor-related apoptosis-inducing ligand, and intestinal fatty acid-binding protein (I-FABP) than survivors. Levels of complement factor 5/5a were higher in survivors compared with fatal cases. IL-6 and I-FABP, the latter a marker for intestinal damage, were by multivariate analyses identified as independent markers associated with disease severity (odds ratio [OR], 2.25; 95% confidence interval [CI], 1.01-5.01) and fatal outcome (OR, 1.64; 95% CI, 1.01-2.64), respectively. CONCLUSIONS: HPS patients displayed a multifaceted, systemic inflammatory response, with IL-6 and I-FABP as independent markers of disease severity and fatality, respectively.
Assuntos
Biomarcadores/metabolismo , Síndrome Pulmonar por Hantavirus/sangue , Síndrome Pulmonar por Hantavirus/metabolismo , Adulto , Citocinas/sangue , Citocinas/metabolismo , Feminino , Orthohantavírus/patogenicidade , Humanos , Masculino , Estudos Retrospectivos , Índice de Gravidade de DoençaRESUMO
Andes virus (ANDV) is the etiological agent of hantavirus cardiopulmonary syndrome in Chile. In this study, we evaluated the profile of the pro-inflammatory cytokines IL-1ß, IL-12p70, IL-21, TNF-α, IFN-γ, IL-10 and IL-6 in serum samples of ANDV-infected patients at the time of hospitalization. The mean levels of circulating cytokines were determined by a Bead-Based Multiplex assay coupled with Luminex detection technology, in order to compare 43 serum samples of healthy controls and 43 samples of ANDV-infected patients that had been categorized according to the severity of disease. When compared to the controls, no significant differences in IL-1ß concentration were observed in ANDV-infected patients (p = 0.9672), whereas levels of IL-12p70 and IL-21 were significantly lower in infected cases (p = <0.0001). Significantly elevated levels of TNF-α, IFN-γ, IL-10, and IL-6 were detected in ANDV-infected individuals (p = <0.0001, 0.0036, <0.0001, <0.0001, respectively). Notably, IL-6 levels were significantly higher (40-fold) in the 22 patients with severe symptoms compared to the 21 individuals with mild symptoms (p = <0.0001). Using multivariate regression models, we show that IL-6 levels has a crude OR of 14.4 (CI: 3.3-63.1). In conclusion, the serum level of IL-6 is a significant predictor of the severity of the clinical outcome of ANDV-induced disease.
Assuntos
Progressão da Doença , Síndrome Pulmonar por Hantavirus/sangue , Síndrome Pulmonar por Hantavirus/epidemiologia , Interleucina-6/sangue , Adolescente , Adulto , Distribuição por Idade , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Criança , Pré-Escolar , Chile/epidemiologia , Citocinas/sangue , Feminino , Orthohantavírus , Síndrome Pulmonar por Hantavirus/fisiopatologia , Humanos , Lactente , Recém-Nascido , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Fatores de Risco , Índice de Gravidade de Doença , Distribuição por Sexo , Adulto JovemRESUMO
BACKGROUND: Currently in Chile, due to the frequent clinical suspicion of Hantavirus disease and the high public health impact that this causes, it is necessary to strengthen the criteria for clinical and epidemiological suspicion in the health team. OBJECTIVE: To analyze the information contained in the reports of suspected Hantavirus infection versus the confirmatory diagnosis with the reference technique, IgM capture ELISA anti-hantavirus. Material andMethods: Correlation between the information provided in notifications versus the result of confirmation was analyzed by calculating diagnostic accuracy. RESULTS: 3.4% of 1,566 patients studied (53 cases) was confirmed as SCPH. 58.6% of the analyzed notifications was incomplete. The percentage of positivity of the reference technique associated with fever, myalgia and headache was 80-85%. The presence of immunoblasts (> 10%) showed 25% sensitivity, 98% specificity, 37% PPV, 97% NPV. Thrombocytopenia exhibited 98% sensitivity, 74% specificity, 16% PPV, 100% NPV. CONCLUSION: It is necessary to reinforce the importance of comprehensive data reporting at the health system level. The presence of thrombocytopenia and immunoblasts (> 10%) is highly sensitive and specific, respectively, for detecting patients with SCPH. There is a need to develop training programs in order to optimize the suspicion of Hantavirus infection and appropriate use of health resources.
Assuntos
Notificação de Doenças/normas , Vírus Hantaan/isolamento & purificação , Síndrome Pulmonar por Hantavirus/diagnóstico , Febre Hemorrágica com Síndrome Renal/diagnóstico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Anticorpos Antivirais/sangue , Criança , Pré-Escolar , Chile , Ensaio de Imunoadsorção Enzimática , Feminino , Síndrome Pulmonar por Hantavirus/sangue , Febre Hemorrágica com Síndrome Renal/sangue , Humanos , Imunoglobulina M/sangue , Lactente , Masculino , Pessoa de Meia-Idade , Padrões de Referência , Valores de Referência , Sensibilidade e Especificidade , Estudos Soroepidemiológicos , Testes Sorológicos/métodos , Trombocitopenia/sangue , Trombocitopenia/diagnóstico , Adulto JovemRESUMO
Antecedentes: Actualmente en Chile, debido a la elevada sospecha clínica de enfermedad por hantavirus y el alto impacto en salud pública que esto provoca, se hace necesario reforzar al equipo de salud, los criterios de sospecha clínica y epidemiológica de hantavirosis. Objetivo: Analizar la información contenida en las notificaciones de sospecha de infección por hantavirus versus la técnica de referencia para el diagnóstico confirmatorio de casos sospechosos, ELISA IgM de captura anti-hantavirus. Material y Método: Mediante cálculo de precisión diagnóstica se analizó la correlación que existe entre la información entregada en las notificaciones versus el resultado de la confirmación mediante la técnica de referencia. Resultados: De 1.566 pacientes estudiados 3,4% (53 casos) fue confirmado para SCPH. De las notificaciones analizadas 58,6% estaban con datos incompletos. Los porcentajes de positividad de la técnica de referencia asociada a fiebre, mialgia y cefalea, fueron de 80-85%. Destaca que la presencia de inmunoblastos (> 10%), presenta: S: 25%, E: 98%, VPP: 37%, VPN: 97%. Paratrombocitopenia se obtuvo: S: 98%, E: 74%, VPP: 16%, VPN: 100%. Conclusión: Se hace necesario reiterar a nivel del sistema sanitario chileno la importancia de contar con datos completos en los formularios de notificación. La presencia de trombocitopenia e inmunoblastos (> 10%) fue altamente sensible y especifica, respectivamente, en la detección de pacientes con SCPH. Con el fin de optimizar la sospecha de infección por hantavirus, según la definición de caso sospechoso, se plantea la necesidad de desarrollar programas de capacitación para la sospecha clínica y lectura de parámetros de laboratorio, tales como presencia de inmunoblastos en el hemograma, así como incluir un algoritmo con el fin de optimizar la sospecha y el uso adecuado de los recursos sanitarios.
Background: Currently in Chile, due to the frequent clinical suspicion of Hantavirus disease and the high public health impact that this causes, it is necessary to strengthen the criteria for clinical and epidemiological suspicion in the health team. Objective: To analyze the information contained in the reports of suspected Hantavirus infection versus the confirmatory diagnosis with the reference technique, IgM capture ELISA anti-hantavirus. Material andMethods: Correlation between the information provided in notifications versus the result of confirmation was analyzed by calculating diagnostic accuracy. Results: 3.4% of 1,566 patients studied (53 cases) was confirmed as SCPH. 58.6% of the analyzed notifications was incomplete. The percentage of positivity of the reference technique associated with fever, myalgia and headache was 80-85%. The presence of immunoblasts (> 10%) showed 25% sensitivity, 98% specificity, 37% PPV, 97% NPV. Thrombocytopenia exhibited 98% sensitivity, 74% specificity, 16% PPV, 100% NPV. Conclusion: It is necessary to reinforce the importance of comprehensive data reporting at the health system level. The presence of thrombocytopenia and immunoblasts (> 10%) is highly sensitive and specific, respectively, for detecting patients with SCPH. There is a need to develop training programs in order to optimize the suspicion of Hantavirus infection and appropriate use of health resources.
Assuntos
Humanos , Masculino , Feminino , Lactente , Pré-Escolar , Criança , Adolescente , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Adulto Jovem , Vírus Hantaan/isolamento & purificação , Síndrome Pulmonar por Hantavirus/diagnóstico , Notificação de Doenças/normas , Febre Hemorrágica com Síndrome Renal/diagnóstico , Padrões de Referência , Valores de Referência , Trombocitopenia/diagnóstico , Trombocitopenia/sangue , Imunoglobulina M/sangue , Ensaio de Imunoadsorção Enzimática , Testes Sorológicos/métodos , Estudos Soroepidemiológicos , Chile , Sensibilidade e Especificidade , Síndrome Pulmonar por Hantavirus/sangue , Febre Hemorrágica com Síndrome Renal/sangue , Anticorpos Antivirais/sangueRESUMO
Andes virus is the causative agent of hantavirus pulmonary syndrome (HPS) in Argentina and neighboring countries. In our country four different areas are affected: Northwest, Southwest, Central and Northeast, where distinct Andes virus genotypes were characterized. Three genotypes were described in Buenos Aires province (Central area): AND-Buenos Aires, AND-Lechiguanas and AND-Plata. In this work, we considered all HPS cases confirmed by ELISA and real time RT-PCR during the period 2009-2014 in Buenos Aires province. The annual distribution, fatality rate and geographic distribution were analyzed. We also analyzed the genotypes involved by RT-PCR and nucleotide sequencing. Finally we evaluated epidemiological data in order to establish the route of transmission. We analyzed 1386 suspect cases of hantavirus infection from Buenos Aires province and we confirmed 88 cases of Hantavirus Pulmonary Syndrome during 2009-2014. The overall average was 14.3 cases per year. The occurrence of a HPS outbreak was confirmed in Buenos Aires province during 2013, showing a 3 fold increase in case number compared to the annual average between 2009 and 2012, tending to normalize during 2014. The overall lethality was 25.6%, with a maximum value of 45.5% in 2011. Genotype analysis was performed in 30.7% of confirmed cases, AND-BsAs show the highest incidence, it was characterized in 72% of the studied cases. Epidemiological data and results of viral genome comparison strongly suggest person-to-person transmission in the three clusters of two cases described in our study.
Assuntos
Síndrome Pulmonar por Hantavirus/epidemiologia , Síndrome Pulmonar por Hantavirus/transmissão , Orthohantavírus/isolamento & purificação , Adolescente , Adulto , Argentina/epidemiologia , Ensaio de Imunoadsorção Enzimática , Feminino , Genótipo , Orthohantavírus/classificação , Síndrome Pulmonar por Hantavirus/sangue , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Características de Residência , Adulto JovemRESUMO
El virus Andes es el agente causante del síndrome pulmonar por hantavirus en Argentina y países limítrofes. Existen varios genotipos característicos en las cuatro regiones endémicas del país. En la provincia de Buenos Aires, zona central, co-circulan tres genotipos: AND-BsAs, AND-Lechiguanas y AND-Plata. A partir de los casos confirmados por ELISA y PCR en tiempo real durante el período 2009-2014 en Buenos Aires, se evaluó la distribución anual, la letalidad y la distribución geográfica dentro de la provincia; mediante RT-PCR y secuenciación nucleotídica se analizaron los genotipos implicados. También se estudió la evidencia epidemiológica para determinar la ruta de infección en casos agrupados. Se analizaron 1386 muestras de casos sospechosos de la provincia de Buenos Aires, confirmándose 88 casos de Síndrome Pulmonar por Hantavirus durante el período 2009-2014. El promedio general fue de 14.3 casos por año. El análisis del genotipo viral se realizó en el 30.7% de los casos confirmados, AND-BsAs fue el de mayor incidencia, caracterizado en el 72% de los casos estudiados. Se confirmó la ocurrencia de un brote de síndrome pulmonar por hantavirus Buenos Aires durante el año 2013, con un registro de casos 3 veces mayor respecto al promedio anual del período 2009-2012, con tendencia a normalizarse durante 2014. La letalidad general fue del 25.6%, con un valor máximo de 45.5% en 2011. Se evaluaron los datos epidemiológicos y los resultados obtenidos del análisis de comparación de genomas virales en 3 agrupamientos de 2 casos cada uno, sugiriendo fuertemente transmisión persona a persona.
Andes virus is the causative agent of hantavirus pulmonary syndrome (HPS) in Argentina and neighboring countries. In our country four different areas are affected: Northwest, Southwest, Central and Northeast, where distinct Andes virus genotypes were characterized. Three genotypes were described in Buenos Aires province (Central area): AND-Buenos Aires, AND-Lechiguanas and AND-Plata. In this work, we considered all HPS cases confirmed by ELISA and real time RT-PCR during the period 2009-2014 in Buenos Aires province. The annual distribution, fatality rate and geographic distribution were analyzed. We also analyzed the genotypes involved by RT-PCR and nucleotide sequencing. Finally we evaluated epidemiological data in order to establish the route of transmission. We analyzed 1386 suspect cases of hantavirus infection from Buenos Aires province and we confirmed 88 cases of Hantavirus Pulmonary Syndrome during 2009-2014. The overall average was 14.3 cases per year. The occurrence of a HPS outbreak was confirmed in Buenos Aires province during 2013, showing a 3 fold increase in case number compared to the annual average between 2009 and 2012, tending to normalize during 2014. The overall lethality was 25.6%, with a maximum value of 45.5% in 2011. Genotype analysis was performed in 30.7% of confirmed cases, AND-BsAs show the highest incidence, it was characterized in 72% of the studied cases. Epidemiological data and results of viral genome comparison strongly suggest person-to-person transmission in the three clusters of two cases described in our study.
Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Adulto Jovem , Orthohantavírus/isolamento & purificação , Síndrome Pulmonar por Hantavirus/transmissão , Síndrome Pulmonar por Hantavirus/epidemiologia , Argentina/epidemiologia , Ensaio de Imunoadsorção Enzimática , Características de Residência , Incidência , Orthohantavírus/classificação , Síndrome Pulmonar por Hantavirus/sangue , GenótipoRESUMO
BACKGROUND: During 2012, a total of 10 overnight visitors to Yosemite National Park (Yosemite) became infected with a hantavirus (Sin Nombre virus [SNV]); three died. SNV infections have been identified among persons with occupational exposure to deer mice (Peromyscus maniculatus). METHODS: We assessed SNV infection prevalence, work and living environments, mice exposures, and SNV prevention training, knowledge, and practices among workers of two major employers at Yosemite during September-October, 2012 by voluntary blood testing and a questionnaire. RESULTS: One of 526 participants had evidence of previous SNV infection. Participants reported frequently observing rodent infestations at work and home and not always following prescribed safety practices for tasks, including infestation cleanup. CONCLUSION: Although participants had multiple exposures to deer mice, we did not find evidence of widespread SNV infections. Nevertheless, employees working around deer mice should receive appropriate training and consistently follow prevention policies for high-risk activities.
Assuntos
Anticorpos Antivirais/sangue , Síndrome Pulmonar por Hantavirus/sangue , Doenças Profissionais/sangue , Peromyscus/virologia , Vírus Sin Nombre/imunologia , Animais , California , Síndrome Pulmonar por Hantavirus/prevenção & controle , Síndrome Pulmonar por Hantavirus/psicologia , Síndrome Pulmonar por Hantavirus/transmissão , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Doenças Profissionais/prevenção & controle , Doenças Profissionais/psicologia , Exposição Ocupacional/prevenção & controle , Parques Recreativos , Estudos Soroepidemiológicos , Inquéritos e QuestionáriosRESUMO
Sin Nombre Hantavirus (SNV, Bunyaviridae Hantavirus) is a Category A pathogen that causes Hantavirus Cardiopulmonary Syndrome (HCPS) with case fatality ratios generally ranging from 30% to 50%. HCPS is characterized by vascular leakage due to dysregulation of the endothelial barrier function. The loss of vascular integrity results in non-cardiogenic pulmonary edema, shock, multi-organ failure and death. Using Electric Cell-substrate Impedance Sensing (ECIS) measurements, we found that plasma samples drawn from University of New Mexico Hospital patients with serologically-confirmed HCPS, induce loss of cell-cell adhesion in confluent epithelial and endothelial cell monolayers grown in ECIS cultureware. We show that the loss of cell-cell adhesion is sensitive to both thrombin and plasmin inhibitors in mild cases, and to thrombin only inhibition in severe cases, suggesting an increasing prothrombotic state with disease severity. A proteomic profile (2D gel electrophoresis and mass spectrometry) of HCPS plasma samples in our cohort revealed robust antifibrinolytic activity among terminal case patients. The prothrombotic activity is highlighted by acute ≥30 to >100 fold increases in active plasminogen activator inhibitor (PAI-1) which, preceded death of the subjects within 48 h. Taken together, this suggests that PAI-1 might be a response to the severe pathology as it is expected to reduce plasmin activity and possibly thrombin activity in the terminal patients.
Assuntos
Citocinas/sangue , Síndrome Pulmonar por Hantavirus/sangue , Síndrome Pulmonar por Hantavirus/virologia , Inibidor 1 de Ativador de Plasminogênio/sangue , Vírus Sin Nombre/fisiologia , Trombina/metabolismo , Animais , Proteínas Sanguíneas/metabolismo , Chlorocebus aethiops , Efeito Citopatogênico Viral , Células Endoteliais/metabolismo , Células Endoteliais/virologia , Síndrome Pulmonar por Hantavirus/diagnóstico , Síndrome Pulmonar por Hantavirus/imunologia , Humanos , Modelos Biológicos , Proteoma , Proteômica/métodos , Estudos Retrospectivos , Índice de Gravidade de Doença , Células VeroRESUMO
Hantavirus hemorrhagic fever with renal syndrome is endemic in Europe and Asia, while hantavirus cardiopulmonary syndrome (HCPS) is endemic in Northern, Central and Southern America. The first case of imported HCPS involving an Italian traveller returning from Cuba is reported.
Assuntos
Síndrome Pulmonar por Hantavirus/virologia , Orthohantavírus/isolamento & purificação , Viagem , Anticorpos Antivirais/sangue , Cuba/epidemiologia , Ensaio de Imunoadsorção Enzimática , Imunofluorescência , Orthohantavírus/imunologia , Síndrome Pulmonar por Hantavirus/sangue , Síndrome Pulmonar por Hantavirus/diagnóstico , Humanos , Itália/etnologia , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase em Tempo RealRESUMO
To confirm circulation of Anajatuba virus in Maranhao, Brazil, we conducted a serologic survey (immunoglobulin G ELISA) and phylogenetic studies (nucleocapsid gene sequences) of hantaviruses from wild rodents and persons with hantavirus pulmonary syndrome. This virus is transmitted by Oligoryzomys fornesi rodents and is responsible for hantavirus pulmonary syndrome in this region.
Assuntos
Reservatórios de Doenças/virologia , Monitoramento Ambiental , Síndrome Pulmonar por Hantavirus/epidemiologia , Orthohantavírus/classificação , Sigmodontinae/virologia , Adulto , Animais , Anticorpos Antivirais/sangue , Brasil/epidemiologia , Busca de Comunicante , Estudos Transversais , Monitoramento Epidemiológico , Feminino , Orthohantavírus/genética , Orthohantavírus/isolamento & purificação , Síndrome Pulmonar por Hantavirus/sangue , Síndrome Pulmonar por Hantavirus/veterinária , Humanos , Imunoglobulina G/sangue , Masculino , Dados de Sequência Molecular , Filogenia , RNA Viral/análise , RNA Viral/genética , Estudos SoroepidemiológicosRESUMO
Choclo virus (CHOV) was described in sigmodontine rodents, Oligoryzomys fulvescens, and humans during an outbreak of hantavirus cardiopulmonary syndrome (HCPS) in 1999-2000 in western Panama. Although HCPS is rare, hantavirus-specific serum antibody prevalence among the general population is high suggesting that CHOV may cause many mild or asymptomatic infections. The goals of this study were to confirm the role of CHOV in HCPS and in the frequently detected serum antibody and to establish the phylogenetic relationship with other New World hantaviruses. CHOV was cultured to facilitate the sequencing of the small (S) and medium (M) segments and to perform CHOV-specific serum neutralization antibody assays. Sequences of the S and M segments found a close relationship to other Oligoryzomys-borne hantaviruses in the Americas, highly conserved terminal nucleotides, and no evidence for recombination events. The maximum likelihood and maximum parsimony analyses of complete M segment nucleotide sequences indicate a close relationship to Maporal and Laguna Negra viruses, found at the base of the South American clade. In a focus neutralization assay acute and convalescent sera from six Panamanian HCPS patients neutralized CHOV in dilutions from 1:200 to 1:6,400. In a sample of antibody-positive adults without a history of HCPS, 9 of 10 sera neutralized CHOV in dilutions ranging from 1:100 to 1:6,400. Although cross-neutralization with other sympatric hantaviruses not yet associated with human disease is possible, CHOV appears to be the causal agent for most of the mild or asymptomatic hantavirus infections, as well as HCPS, in Panama.
Assuntos
Síndrome Pulmonar por Hantavirus/virologia , Orthohantavírus/classificação , Adulto , Animais , Anticorpos Neutralizantes/sangue , Anticorpos Neutralizantes/imunologia , Anticorpos Antivirais/sangue , Anticorpos Antivirais/imunologia , Proteínas do Capsídeo/genética , Pré-Escolar , Orthohantavírus/genética , Orthohantavírus/isolamento & purificação , Síndrome Pulmonar por Hantavirus/sangue , Síndrome Pulmonar por Hantavirus/epidemiologia , Humanos , Pessoa de Meia-Idade , Dados de Sequência Molecular , Panamá/epidemiologia , Filogenia , RNA Viral , Estudos Soroepidemiológicos , Proteínas do Core Viral/genéticaRESUMO
BACKGROUND: Sin Nombre virus (SNV) is the primary cause of hantavirus pulmonary syndrome (HPS) in the United States. Although other studies have demonstrated a possible association between neutralizing antibody titers and the severity of HPS, the exact nature of serologic responses and their association with outcomes have not been fully characterized. METHODS: We examined immunoglobulin M (IgM) and immunoglobulin G (IgG) serologic responses in 94 clinical samples from 81 patients with confirmed HPS. We further compared a subset of 31 patients with fatal HPS and 20 surviving patients for whom samples were available within a week after the onset of HPS. RESULTS: SNV-specific IgM antibodies displayed a trend suggesting an early peak, whereas IgG antibody values peaked later. Among individuals with samples from the first week after the onset of HPS, all surviving patients had SNV-specific IgG responses, compared with <50% of patients with fatal HPS, and the distribution of IgG responses was significantly higher in surviving patients. CONCLUSIONS: Production of SNV-specific IgM antibodies occurs early during the clinical course of HPS, whereas production of IgG antibodies may be more protracted. The presence and overall distribution of higher IgG antibody titers in surviving patients with HPS suggests that production of SNV-specific IgG may be a strong predictor of favorable outcomes.
Assuntos
Anticorpos Antivirais/sangue , Síndrome Pulmonar por Hantavirus/imunologia , Imunoglobulina G/sangue , Imunoglobulina M/sangue , Orthohantavírus/imunologia , Vírus Sin Nombre/patogenicidade , Centers for Disease Control and Prevention, U.S. , Síndrome Pulmonar por Hantavirus/sangue , Síndrome Pulmonar por Hantavirus/mortalidade , Humanos , Valor Preditivo dos Testes , Vírus Sin Nombre/imunologia , Análise de Sobrevida , Sobreviventes , Resultado do Tratamento , Estados UnidosRESUMO
BACKGROUND: Hantavirus pulmonary syndrome (HPS) is an emerging rodent-borne disease in the American continent, characterized by acute respiratory distress and a high case-fatality ratio. The present work describes a case of HPS, with favorable outcome, whose initial features were mistaken for leptospirosis or other less severe acute infections. METHODOLOGY: The case of a 32-year-old male with an uneventful course of HPS is reported. He was inadvertently infected at work by exposure to a rodent-contaminated environment in Brasília, Federal District vicinity, during May 2008. RESULTS AND CONCLUSIONS: Fever, headache and myalgia after exposure to a rodent-contaminated environment raised clinical suspicion. Non-cardiac pulmonary edema, hydrothorax, neutrophilia with band forms 26%, high hematocrit, thrombocytopenia, and elevated liver enzymes were observed. Leptospirosis and dengue were the main differential diagnoses because both pathogens are endemic in the area. Hantavirus IgM antibody-capture ELISA was positive, while tests for dengue, leptospirosis and yellow fever were negative. The prognosis for HPS is ominous and misdiagnoses may increase mortality. Better chances of survival depend on prompt intensive care support. Reports of moderate or less typical cases can raise the suspicion index among primary care and hospital-based physicians about this uncommon but severe condition that often affects previously healthy young individuals from developing countries, and subjects who interact with rodent-infested environments in North America. High awareness of HPS allowed successful management of the patient, even before establishing the diagnosis, by serological tests at the reference laboratory of the Ministry of Health. Clinical suspicion favored warning local health authorities about a new case of HPS.
Assuntos
Anticorpos Antivirais/sangue , Síndrome Pulmonar por Hantavirus/diagnóstico , Imunoglobulina M/sangue , Adulto , Brasil , Diagnóstico Diferencial , Síndrome Pulmonar por Hantavirus/sangue , Humanos , MasculinoRESUMO
Laboratory diagnosis of hantavirus cardiopulmonary syndrome (HCPS) in Brazil has been performed mostly by detection of IgM antibodies to recombinant antigen purified from Sin Nombre virus and Andes virus (ANDV). Recently, a recombinant nucleocapsid (rN) protein of Araraquara virus (ARAV), a Brazilian hantavirus, was obtained in Escherichia coli. To evaluate ARAV rN as antigen for antibody detection, serum samples from 30 patients from Argentina seropositive for hantavirus were tested. All samples were positive for IgG and IgM by enzyme-linked immunosorbent assay (ELISA) using either ARAV rN or ANDV rN antigens. In Brazil, six of 60 serum samples from patients with suspected HCPS (10%) were positive for IgM by ELISA using ARAV rN antigen and 7 were positive using ANDV rN antigen. For results obtained with 90 serum samples analyzed by IgM ELISA with ANDV rN antigen, the sensitivity of the IgM ELISA using ARAV rN antigen was 97.2%, the specificity was 100%, the positive predictive value was 100%, and the negative predictive value was 98.1%. The results show that ARAV rN is a suitable antigen for diagnosis of hantavirus infection in Brazil and Argentina.
Assuntos
Ensaio de Imunoadsorção Enzimática/métodos , Síndrome Pulmonar por Hantavirus/diagnóstico , Orthohantavírus , Adolescente , Adulto , Idoso , Anticorpos Antivirais/sangue , Antígenos Virais/sangue , Argentina , Criança , Pré-Escolar , Feminino , Síndrome Pulmonar por Hantavirus/sangue , Humanos , Imunoglobulina G/sangue , Imunoglobulina M/sangue , Masculino , Pessoa de Meia-Idade , Adulto JovemRESUMO
Hantavirus cardiopulmonary syndrome (HCPS) is a highly pathogenic emerging disease (40% case fatality rate) caused by New World hantaviruses. Hantavirus infections are transmitted to humans mainly by inhalation of virus-contaminated aerosol particles of rodent excreta and secretions. At present, there are no antiviral drugs or immunotherapeutic agents available for the treatment of hantaviral infection, and the survival rates for infected patients hinge largely on early virus recognition and hospital admission and aggressive pulmonary and hemodynamic support. In this study, we show that Andes virus (ANDV) interacts with human apolipoprotein H (ApoH) and that ApoH-coated magnetic beads or ApoH-coated enzyme-linked immunosorbent assay plates can be used to capture and concentrate the virus from complex biological mixtures, such as serum and urine, allowing it to be detected by both immunological and molecular approaches. In addition, we report that ANDV-antigens and infectious virus are shed in urine of HCPS patients.
Assuntos
Antígenos Virais/urina , Síndrome Pulmonar por Hantavirus/urina , Orthohantavírus/imunologia , beta 2-Glicoproteína I/imunologia , Animais , Anticorpos Monoclonais/imunologia , Anticorpos Antivirais/sangue , Anticorpos Antivirais/imunologia , Antígenos Virais/sangue , Antígenos Virais/imunologia , Chlorocebus aethiops , Ensaio de Imunoadsorção Enzimática , Síndrome Pulmonar por Hantavirus/sangue , Síndrome Pulmonar por Hantavirus/imunologia , Humanos , Imunoglobulina G/sangue , Imunoglobulina G/imunologia , Microesferas , RNA Viral/análise , Células VeroRESUMO
In May 2005, a cluster of four hantavirus pulmonary syndrome (HPS) cases was confirmed in Alberta, Canada. The cluster is unusual given that three cases were from a single family and involved a 7-year-old child. This is the first family cluster reported in Canada and includes one of the youngest cases of HPS reported in North America.